Evaluation of nisin-β-lactam antibiotics against clinical strains of Salmonella enterica serovar Typhi

Journal of Antibiotics

Volumn 67, Issue 12, 2014, Pages 807-811

  Rishi, Praveen ^a   Preet Singh, Aman ^a   Garg, Neha ^a   Rishi, Madhuri ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFALEXIN; CEFALOTIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; FURAZOLIDONE; GATIFLOXACIN; GENTAMICIN; NALIDIXIC ACID; NETILMICIN; NISIN; NORFLOXACIN; OXYTETRACYCLINE; ANTIINFECTIVE AGENT; BETA LACTAM; NISIN A;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BROTH DILUTION; COLONY FORMING UNIT; CONTROLLED STUDY; DISK DIFFUSION; DRUG POTENTIATION; FRACTIONAL INHIBITORY CONCENTRATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; TIME; DRUG COMBINATION; DRUG EFFECTS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; SALMONELLA ENTERICA SEROVAR TYPHI; TYPHOID FEVER;

MURINAE; SALMONELLA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; MICROBIAL SENSITIVITY TESTS; NISIN; SALMONELLA TYPHI; TYPHOID FEVER;

EID: 84925286737     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.1038/ja.2014.75     Document Type: Article

References (24)

1. Tsolis, R. M., Xavier, M. N., Santos, R. L., Baümler, A. J. How to become a top model: impact of animal experimentation on human Salmonella disease research. Infect. Immun. 79, 1806-1814 (2011).
2. Siddiqui, F. J., Rabbani, F., Hasan, R., Nizami, S. Q., Bhutta, Z. A. Typhoid fever in children: some epidemiological considerations from Karachi, Pakistan. Int. J. Infect Dis. 10, 215-222 (2006).
3. Ochiai, R. L., Acosta, C. J., Danovaro-Holliday, M. A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bull. World Health Organ. 86, 260-268 (2008).
4. Threlfall, E. J., Skinner, J. A., Ward, L. R. Detection of decreased in vitro susceptibility to ciprofloxacin in Salmonella enterica serotypes typhi and paratyphi A. J. Antimicrob. Chemother. 48, 740-741 (2001).
5. Joerger, R. D. Alternatives to antibiotics: bacteriocins, antimicrobial peptides and bacteriophages. Poult. Sci. 82, 640-647 (2003).
6. Birosova, L., Mikulasova, M. Development of triclosan and antibiotic resistance in Salmonella enterica serovar Typhimurium. J. Med. Microbiol. 58, 436-441 (2009).
7. Singh, A. P., Prabha, V., Rishi, P. Value addition in the efficacy of conventional antibiotics by nisin against Salmonella. PLoS ONE 8, e76844 (2013).
8. Field, D. et al. Bioengineered nisin A derivatives with enhanced activity against both Gram positive and Gram negative pathogens. PLoS ONE 7, e46884 (2012).
9. Boziaris, I. S., Adams, M. R. Effect of chelators and nisin produced in situ on inhibition and inactivation of Gram negatives. Int. J. Food Microbiol. 53, 105-113 (1999).
10. Cassone, M., Otvos, L. Jr. Synergy among antibacterial peptides and between peptides and small-molecule antibiotics. Expert Rev. Anti Infect. Ther. 8, 703-716 (2010).
11. Bauer, A. W., Kirby, W. M., Sherris, J. C., Turck, M. Antimicrobial susceptibility testing by a standardized single disc method. Am. J. Clin. Pathol. 45, 493-496 (1966).
12. Clinical and Laboratory Standards Institute. M100-S20. Performance Standards for Antimicrobial Susceptibility Testing: 20th Informational Supplement, CLSI, Wayne, PA, USA (2010).
13. Rishi, P., Preet, S., Bharrhan, S., Verma, I. In-vitro and in-vivo synergistic effects of cryptdin 2 and ampicillin against Salmonella. Antimicrob. Agents Chemother. 55, 4176-4182 (2011).
14. Chuang, C. et al. Surveillance of antimicrobial resistance of Salmonella enterica serotype Typhi in seven Asian countries. Epidemiol. Infect. 137, 266-269 (2009).
15. Maskey, A. P. et al. Emerging trends in enteric fever in Nepal: 9124 cases confirmed by blood culture 1993-2003. Trans. R. Soc. Trop. Med. Hyg. 102, 91-95 (2008).
16. Chalon, M. C., Acuñ a, L., Morero, R. D., Minahk, C. J., Bellomio, A. Membrane-active bacteriocins to control Salmonella in foods: are they the definite hurdle? Food Res. Int. 45, 735-744 (2012).
17. Majtan, J., Majtanova, L., Majtan, V. Increasing trend of resistance to nalidixic acid and emerging ceftriaxone and ciprofloxacin resistance in Salmonella enterica serovar Typhimurium in Slovakia, 2005 to 2009. Diagn. Microbiol. Infect. Dis. 68, 86-88 (2010).
18. Ye, J. et al. Analysis of pSC138, the multidrug resistance plasmid of Salmonella enterica serotype Choleraesuis SC-B67. Plasmid 65, 132-140 (2011).
19. Cotter, P. D., Ross, R. P., Hill, C. Bacteriocins-a viable alternative to antibiotics? Nat. Rev. Microbiol. 11, 95-105 (2013).
20. Freeman, M. F. et al. Metagenome mining reveals polytheonamides as posttranslationally modified ribosomal peptides. Science 338, 387-390 (2012).
21. Ruhr, E., Sahl, H. G. Mode of action of the peptide antibiotic nisin and influence on the membrane potential of whole cells and on cytoplasmic and artificial membrane vesicles. Antimicrob. Agents Chemother. 27, 841-845 (1985).
22. Gut, I. M., Blanke, S. R., van der Donk, W. A. Mechanism of inhibition of Bacillus anthracis spore outgrowth by the lantibiotic nisin. ACS Chem. Biol. 6, 744-752 (2011).
23. Kohanski, M. A., Dwyer, D. J., Collins, J. J. How antibiotics kill bacteria: from targets to networks. Nat. Rev. Microbiol. 8, 423-435 (2010).
24. Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A., Collins, J. J. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130, 797-810 (2007).